Eugene Sun

Eugene Sun is a highly accomplished medical professional with a diverse educational background. He pursued a Bachelor's degree in Applied Mathematics from Harvard University, an M.D. in Medicine from New York University School of Medicine, and completed Internship, Residency, and Fellowship programs at the University of California, San Francisco (UCSF).

Throughout his career, Eugene Sun held prominent positions in various prestigious organizations. He has served as the CEO of Melinta Therapeutics, Senior Vice President of Research and Development at TB Alliance, Executive Vice President at Melinta Therapeutics, and Corporate Vice President of Global Pharmaceutical Clinical Development at Abbott Laboratories. Additionally, he worked as a Director at Novan, Inc., held roles at Abbott Laboratories in Global Pharmaceutical Development and Antiviral Venture Head positions, and served as a Pharmaceutical Executive and Senior Medical Advisor at various organizations.

His extensive experience also includes roles in academia, where he worked as an Assistant Professor in the Infectious Diseases Division of the Department of Medicine at the University of California, San Francisco. Furthermore, he contributed to the healthcare sector by serving as a member of the Antiviral Drugs Advisory Committee at the Food and Drug Administration (FDA). Eugene Sun's expertise spans across research and development, clinical development, pharmaceuticals, and infectious diseases.